[Opiatergic mechanisms of cardioprotective and anti-arrhythmic effects of adaptation].
Lishmanov
Iu B
IuB
Maĭmeskulova
L A
LA
Uskina
E V
EV
Maslov
L N
LN
D000222:Adaptation, Physiological; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control*; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D004837:Epinephrine / Q000633:toxicity; D006321:Heart / Q000187:drug effects / Q000503:physiopathology*; D000860:Hypoxia / Q000503:physiopathology; D007103:Immobilization; D008297:Male; D009271:Naltrexone / Q000031:analogs & derivatives / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D010936:Plant Extracts / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar
D009292:Narcotic Antagonists; D010936:Plant Extracts; C051844:norbinaltorphimine; D004743:Enkephalin, Leucine; D009271:Naltrexone; C040643:N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine; C055382:naltrindole; D004837:Epinephrine